Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Byng-Maddick

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
BMC Infectious Diseases|March 13, 2016
Does tuberculosis threaten our ageing populations?Rachel Byng-Maddick, Mahdad Noursadeghi
British Journal of Hospital Medicine (London, England : 2005)|November 6, 2012
Infections in biological agents used in rheumatic diseaseRachel Byng-Maddick, Michael Ehrenstein
Clinical Medicine (London, England)|August 3, 2016
Options for taking time out of specialty trainingRachel Byng-Maddick, Karen Walker-Bone
Rheumatology (Oxford, England)|February 11, 2015
The impact of biological therapy on regulatory T cells in rheumatoid arthritisRachel Byng-Maddick, Michael R Ehrenstein
Quality in Primary Care|April 2, 2013
Primary care attitudes to methotrexate monitoringRachel Byng-Maddick, Madhavi Wijendra, Henry Penn
Clinical Rheumatology|October 31, 2012
Management of persistent inflammatory large joint monoarthritisRachel Byng-Maddick, Lukshmy Jeyalingam, Andrew Keat
Rheumatology (Oxford, England)|July 10, 2018
Biologic prescribing decisions following serious infection: results from the British Society for Rheumatology Biologics Register-Rheumatoid ArthritisSujith Subesinghe, Andrew Ian Rutherford, Rachel Byng-Maddick, et al.
Rheumatology (Oxford, England)|January 18, 2018
Recurrent serious infections in patients with rheumatoid arthritis-results from the British Society for Rheumatology Biologics RegisterSujith Subesinghe, Andrew Ian Rutherford, Rachel Byng-Maddick, et al.
Frontiers in Immunology|August 22, 2017
Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF TherapyRachel Byng-Maddick, Carolin T Turner, Gabriele Pollara, et al.
Plos One|January 4, 2017
Validation of Immune Cell Modules in Multicellular Transcriptomic DataGabriele Pollara, Matthew J Murray, James M Heather, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Infectious Diseases|March 13, 2016
Does tuberculosis threaten our ageing populations?Rachel Byng-Maddick, Mahdad Noursadeghi
British Journal of Hospital Medicine (London, England : 2005)|November 6, 2012
Infections in biological agents used in rheumatic diseaseRachel Byng-Maddick, Michael Ehrenstein
Clinical Medicine (London, England)|August 3, 2016
Options for taking time out of specialty trainingRachel Byng-Maddick, Karen Walker-Bone
Rheumatology (Oxford, England)|February 11, 2015
The impact of biological therapy on regulatory T cells in rheumatoid arthritisRachel Byng-Maddick, Michael R Ehrenstein
Quality in Primary Care|April 2, 2013
Primary care attitudes to methotrexate monitoringRachel Byng-Maddick, Madhavi Wijendra, Henry Penn
Clinical Rheumatology|October 31, 2012
Management of persistent inflammatory large joint monoarthritisRachel Byng-Maddick, Lukshmy Jeyalingam, Andrew Keat
Rheumatology (Oxford, England)|July 10, 2018
Biologic prescribing decisions following serious infection: results from the British Society for Rheumatology Biologics Register-Rheumatoid ArthritisSujith Subesinghe, Andrew Ian Rutherford, Rachel Byng-Maddick, et al.
Rheumatology (Oxford, England)|January 18, 2018
Recurrent serious infections in patients with rheumatoid arthritis-results from the British Society for Rheumatology Biologics RegisterSujith Subesinghe, Andrew Ian Rutherford, Rachel Byng-Maddick, et al.
Frontiers in Immunology|August 22, 2017
Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF TherapyRachel Byng-Maddick, Carolin T Turner, Gabriele Pollara, et al.
Plos One|January 4, 2017
Validation of Immune Cell Modules in Multicellular Transcriptomic DataGabriele Pollara, Matthew J Murray, James M Heather, et al.
Pageof 2